Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
RLK-Pharma Oy
OY
Dissolved
Y-tunnus 2800399-1
Männistönkatu 3B-384, 33410
Tampere
Retail sale of medical and orthopaedic goods
·
NACE 4774
Est. 2016 · 9 years old
— employees
Share
Finland
/
Companies
/
Retail sale of medical and orthopaedic goods
/
RLK-Pharma Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
1M
2023
0M
2024
0M
2025
EBITDA
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
EUR thousands
Item
2021
2022
2023
2024
2025
Revenue
568
561
574
123
0
Staff expenses
−0
−0
−0
−0
−0
EBITDA
149
155
150
29
−8
Depreciation & amort.
−9
−6
−5
−4
−3
EBIT
141
149
145
26
−10
Net financials
−0
1
1
14
3
Profit before tax
141
150
146
40
−8
Tax
28
30
29
8
−0
Net profit
113
120
117
32
−8
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
2025
Total assets
451
548
611
576
521
Equity
429
515
590
575
521
Long-term debt
—
—
0
0
0
Short-term debt
22
33
21
1
0
Total debt
22
33
21
1
0
Financial ratios
5-year trend
EBITDA-margin
-766600.0%
This company
15.8%
Market median
-4851999% vs market
2021
2025
Soliditetsgrad
100.0%
This company
38.2%
Market median
+162% vs market
2021
2025
Egenkapitalforrentning
-1.5%
This company
18.4%
Market median
-108% vs market
2021
2025
Nettoresultatgrad
-762500.0%
This company
8.1%
Market median
-9413680% vs market
2021
2025
Aktivomsætning
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Gæld/egenkapital
0.00×
This company
0.62×
Market median
+100% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on RLK-Pharma Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
